MedDataX Logo

Pain Management in Geriatric Hip Fracture

NCT ID: NCT01630343

Last Updated: 2012-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Null Hypothesis is that there is no association between Pain regime and the functional performance among geriatric patients having traumatic hip fracture. Two limbs are being assessed:1. Three weeks of regular oral Panadol and Tramadol after hip fracture 2. Oral Panadol and tramadol taking in p.r.n. basis. Functional outcome including Numerical Rate Scale for pain assessment, Functional Independency Measure and Elderly Mobility Score are chosen.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

200X2 patients are recruited during two periods within the study period where regular oral analgesics is given for the first 200 patients while the rest of patient will receive oral analgesics upon demand

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Geriatric Hip Fracture Pain Management

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Geriatric hip fracture pain management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Regular oral Panadol and Tramadol

Geriatric (age \>65) Patient having traumatic hip fracture will have three weeks of regular prescription of oral Panadol(500mg) and tramadol (50mg) three times a day. Operation will be done within 3 days usually followed by rehabilitation period.

Group Type EXPERIMENTAL

Panadol 500mg tablet, tramadol 50mg capsule

Intervention Type DRUG

Regular Panadol 500mg tds with tramadol 50mg capsule tds for 3 weeks after injury

Panadol and tramadol oral in prn basis

Control group is that patient having geriatric hip fracture will have oral analgesics ( Panadol 500mg Q4H and tramadol 50mg Q4H ) in prn basis.

Group Type EXPERIMENTAL

Paracetamol tablet and Tramadol capsule

Intervention Type DRUG

Panadol 500mg tablet Q4H prn Tramadol 50mg capsule Q4H prn

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paracetamol tablet and Tramadol capsule

Panadol 500mg tablet Q4H prn Tramadol 50mg capsule Q4H prn

Intervention Type DRUG

Panadol 500mg tablet, tramadol 50mg capsule

Regular Panadol 500mg tds with tramadol 50mg capsule tds for 3 weeks after injury

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Endpain, tramadol Endopain, tramadol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both sex of Age \> 65
* Traumatic non-pathological fracture neck of femur or trochanteric or subtrochanteric fracture having operative intervention

Exclusion Criteria

* Age \< 65
* Pathological fracture
* Multiple lower limb fractures
* Old fracture
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Queen Elizabeth Hospital, Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ho Chin Hung

Associate Consultant (Orthopaedics and Traumatology)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chin Ping Hong, Raymond, FRCSE(Edin)

Role: STUDY_DIRECTOR

The Queen Elizabeth Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Orthopaedics and Traumatology, Queen Elizabeth Hospital

Hong Kong SAR, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QEHHIPPAIN

Identifier Type: -

Identifier Source: org_study_id